“Orphan drugs” are medicinal products intended for diagnosis, prevention or treatment of life-threatening or very serious diseases or disorders that are rare.
A disease or disorder is defined as rare in Europe when it affects less than 1 in 2,000 citizens.
These drugs are called “orphan” because under normal market conditions the pharmaceutical industry has little interest in developing and marketing products intended for only a small number of patients.
For drug companies, the extremely high cost of bringing a medicinal product to market would not be recovered by the expected sales of the product.
We are able to provide medicines under this category. please contact us for further information.
- CATEGORY Orphan